Dr. Sharon Elad’s research was recently published in the journal with the highest impact factor (508.72) CA: A Cancer Journal for Clinicians. The chair of EIOH's Oral Medicine Department's study is titled “The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies.”
Oral mucositis is a common, highly symptomatic complication of cancer therapy which impacts patients’ function, quality of life and ability to tolerate treatment. In certain cancer patients, oral mucositis is associated with increased mortality. Oral mucosal toxicities are also reported in targeted and immune check-point inhibitors therapies. This paper presents current knowledge about the epidemiology, pathogenesis, assessment, risk prediction, and current and developing intervention strategies for oral mucositis and other ulcerative mucosal toxicities due to both conventional and evolving forms of cancer therapy.
Dr. Mohammed Baig (Prostho ’11, GenDen ’13) was elected to the International Academy for Dental Facial Esthetics. The Academy recognized his service and devotion to advancing the various arts of esthetics in dentistry and medicine.
Dr. Mohamed Mahmoud (Gen Den ’21) earned a Research Award at the American Prosthodontics Society annual meeting last week for his study “Immediate Loading of Dental Implants Supporting Mandibular Overdenture in Type II Diabetic Patients.” Dr. Konstantinos Chochlidakis (Prostho '13) was elected as one of the five councilors of the American Prosthodontics Society Executive Council.
Dr. David Fraser (Perio ’17, MS ’17) was awarded a Trainee Pilot Study through the University of Rochester’s Clinical & Translational Science Institute and a Joan Wright Goodman Fellowship, the University’s most competitive dissertation fellowship.